{
  "id": 16048792,
  "title": "All-or-Nothing Biotech Bets Dented by Rising Treasury Yields",
  "url": "https://urgent.news/2026/10/22/all-or-nothing-biotech-bets-dented-by-rising-treasury-yields",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-22T12:30:08.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/articles/2026-10-22/all-or-nothing-biotech-bets-dented-by-rising-treasury-yields"
  },
  "original_language": "en",
  "account": null,
  "summary": "Investors are beginning to turn cautious on biotechnology stocks as a rapid rise in Treasury yields dents the appeal for shares of companies that are often viewed as risky all-or-nothing bets on breakthrough medical treatments.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}